Recently we characterized three distinct GnRH receptors in the bullfrog (bfGnRHR-1, bfGnRHR-2, and bfGnRHR-3). In the present study, we further investigated the expression and function of splice variants, generated from the primary bfGnRHR-3 transcript by exon skipping (splice variant 1), intron retention (splice variants 2 and 3), and/or transcriptional slippage (splice variant 4), apart from the constitutively spliced form (wild-type). Cellular expression and function of the splice variants were examined using a transient expression system. Immunoblot analysis revealed that the wild-type receptor and all splice variant proteins were expressed in transfected HeLa cells with no significant differences in expression levels. These splice variants showed a very low binding affinity to ligand and did not induce signal transduction in response to GnRH treatment. 
I
T IS WELL established that a hypothalamic decapeptide, GnRH, plays a central role in regulating vertebrate reproduction (1) . Recently it has been found that, in addition to the hypothalamic form of GnRH (mammalian GnRH, mGnRH), a second form of GnRH (chicken GnRH-II, cGnRH-II) and/or a third form of GnRH (salmon GnRH, sGnRH) were found to exist in brain regions of a wide range of vertebrate species (2) (3) (4) (5) (6) (7) . These GnRHs appear to be involved in neuroendocrine modulation of gonadotropin secretion or reproductive behavior (7, 8) . The presence of two or more forms of GnRH in a single species, moreover, suggests concomitant evolution of two or more types of cognate receptors (9) . Recently, two different GnRH receptors (GnRHRs) have been identified in the goldfish (10) . However, because these GnRHRs share 71% identity and are mainly expressed in the pituitary, they appear to arise from a recent gene duplication and belong to the same type of GnRHR (pituitary type GnRHR).
Recently, we have cloned three different GnRHR cDNAs from the bullfrog, designated bfGnRHR-1, bfGnRHR-2, and bfGnRHR-3, respectively (11) . These receptors share about approximately 40 -45% amino acid identity and exhibit different tissue distributions and ligand selectivity. The bfGnRHR-1 was predominantly expressed in the pituitary, indicating that bfGnRHR-1 may play a classical role in the neuroendocrine control of gonadotropin secretion. However, bfGnRHR-2 and -3 were mainly expressed in various brain regions, suggesting that they may play a role in other brain functions. Although the function of bfGnRHR-2 and -3 in the brain remains to be elucidated, they probably interact with cGnRH-II (and/or sGnRH if sGnRH exists in the bullfrog) whose cell bodies are localized in the midbrain and projecting to the spinal cord and posterior hypothalamic area (12) . All three bfGnRHRs exhibited the typical characteristics of nonmammalian GnRHRs (10, 13, 14) . All bfGnRHRs contain the cytoplasmic carboxyl tail that is absent in mammalian GnRHRs (15, 16) . The Asn 2.50 residue in transmembrane domain 2 (TM2) that is important for interaction with Asp 7.49 residue in TM7 of the mammalian GnRHR is changed to Asp in bfGnRHRs (17) . All bfGnRHRs responded better to cGnRH-II than mGnRH, whereas the mammalian GnRHR was more sensitive to mGnRH than cGnRH-II (18) . Interestingly, the bfGnRHR-3 was most sensitive to sGnRH among the natural GnRHs examined (11) . Although the sGnRH gene has not yet been identified in other vertebrates than in fishes, a recent study revealed the presence of a sGnRH-like peptide in mammalian brain (6) , suggesting a possible interaction of the bfGnRHR-3 with sGnRH.
Northern blot and RT-PCR analysis revealed that each bfGnRHR gene produces multiple transcripts by alternative RNA processing and/or alternative use of transcriptional initiation sites as found in the mammalian GnRHR genes (19 -21) . Northern blot analysis indicated the presence of at least four different bfGnRHR-1 mRNA species (11) . RT-PCR analysis revealed that there is one additional bfGnRHR-2 splice variant (sv), which is presumed to be generated by partial deletion of exon 1 (unpublished data). In this study we will describe the existence of four bfGnRHR-3 sv's produced by alternative splicing procedures including exon skipping, partial retention of intronic sequences, and/or transcriptional slippage. The relative abundance of bfGnRHR-3 sv's in the brain and pituitary, and the production of different proteins derived from the sv's, suggest that these sv's may play a role in modulating the biological effect of GnRH. To elucidate the biological relevance of these sv's, we analyzed cellular expression and responsiveness of the bfGnRHR-3 sv's to GnRH, and examined the effect of the sv's on wild-type (wt) bfGnRHR-3 signaling in a transient expression system. In addition, the expression levels of the bfGnRHR-3 wt and sv transcripts were examined in hibernation and the prebreeding season. 
Materials and Methods Materials

Animals and tissue preparation
Bullfrogs were purchased from the local market in Kwangju, Korea, housed in flow-through tanks under simulated natural conditions. Frogs were killed by decapitation. The tissues of interest were quickly dissected, immediately frozen in liquid nitrogen, and stored at Ϫ80 C until use.
Isolation of bfGnRHR-3 sv cDNA
Total RNA was extracted using Tri-reagent (Sigma) according to the manufacturer's instructions. Poly-(A)
ϩ RNA was purified from total RNA using QIAGEN Oligotex mRNA kit (QIAGEN, Chatsworth, CA). The wt bfGnRHR-3 cDNA containing the entire open reading frame was characterized as described previously (11) . The bfGnRHR-3 sv cDNAs were identified by RT-PCR amplification using bullfrog cDNAs from various brain regions and pituitary with primers flanking the coding region: bf3-start, 5Ј-CGCGAATTCGCCACCATGAACGCTAGTGAC-CAACCTATGG-3Ј [containing an EcoRI site (underlined)], a Kozak translation initiation site (italics), and the N-terminal coding region of bfGnRHR-3 cDNA (bold), and bf3-stop, 5Ј-CGCCTCTAGATTCACATA-AAGCTCTCTACGATTTGAC-3Ј [containing an XbaI site (underlined), and the C-terminal coding region of the bfGnRHR-3 cDNA (bold)], respectively. The PCR products were inserted into the EcoRI and XbaI sites of pcDNA3, yielding the pc-sv1, pc-sv2, pc-sv3, and pc-sv4 constructs.
Determination of exon-intron boundaries of the bfGnRHR-3 gene
Genomic DNA was isolated from liver using a genomic DNA isolation kit (QIAGEN). To determine the genomic organization of the bfGnRHR-3 gene, primers flanking the presumptive splice sites were designed: bf3-intron A-F, 5Ј-ATCTTGAACCCGTTGGGCATAG-3Ј; bf3-intron A-R, 5Ј-GTTGTACAGGGTCTCCAACCAGTG-3Ј; bf3-intron B-F, 5Ј-CCGCTCCTCATCATGGTCTT-3Ј; bf3-intron B-R, 5Ј-CATCCGAGC-CCGCGGGATG-3Ј. PCR products of approximately 0.8 kb (containing intron A) and approximately 2.5 kb (containing intron B) were obtained, subcloned, and sequenced using the Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer Corp.) and an automated ABI prism 377 DNA sequencer (Perkin-Elmer Corp.).
Epitope tagged bfGnRHR-3 cDNA constructs and Western blot analysis
A stretch of nucleotides coding for a nine amino acid epitope (YPY-DVPDYA) derived from the influenza virus hemagglutinin protein (HAtag) was inserted just after the initiating methionine residue in the extracellular N-terminal part of the bfGnRHR-3 wt and sv cDNAs by PCR with Vent R DNA polymerase using the HA-start primer, 5Ј-CGCAAGCTTGCCACCATGTACC-CATACGACGTGCCAGACTACGC-GAACGCTAGTGACCAACCTATGG-3Ј [containing a HindIII site (underlined), a Kozak translation initiation site, an HA-tag coding sequence (italics), the N-terminal coding part of bfGnRHR-3 cDNA (bold)], in combination with the bf3-stop primer (see above). PCR products were digested with HindIII and XbaI and inserted into the HindIII and XbaI sites of pcDNA3, yielding the HA-wt, HA-sv1, HA-sv2, HA-sv3, and HA-sv4 constructs. All constructs were sequenced.
HeLa cells were maintained at 37 C in DMEM with 10% heat-inactivated FBS, 1 mm glutamate, 100 U of penicillin, and 100 g/ml streptomycin. HeLa cells were plated in 100-mm dishes and transfected with HA-wt and HA-sv constructs using the SuperFect transfection kit (QIAGEN). Forty-eight hours after transfection the cells were washed twice with chilled PBS, solubilized in 0.5 ml of lysis buffer with protease inhibitors (50 mm Tris-HCl, pH 8.0; 150 mm NaCl; 0.5% Nonidet P-40; 10 mm NaF; 1 mm sodium orthovanadate; 1 mm dithiothreitol; 10 g/ml leupeptin; 10 g/ml aprotinin; 10 g/ml trypsin/chymotrypin inhibitor; 5 g/ml pepstatin A; and 1 mm phenylmethylsulfonyl fluoride) and frozen at Ϫ80 C. The lysates were cleared by centrifugation. The supernatants were immunoprecipitated with anti-HA antibody overnight at 4 C and then incubated with Protein A-Sepharose beads (Amersham Pharmacia Biotech, Buckinghamshire, UK) to absorb the immunoprecipitates for 4 h. The beads were washed six times with 1 ml of lysis buffer. Bound proteins were eluted with an equal amount of SDSloading buffer (0.125 m Tris-HCl; 4% SDS; 20% (vol/vol) glycerol; 0.2 m dithiothreitol; and 0.02% Bromophenol Blue, pH 6.8). The immunoprecipitates were separated by 12% SDS-PAGE and transferred onto nitrocellulose membrane. The membranes were blocked in PBS with 0.1% Tween 20 and 5% dried milk overnight, and then probed with anti-HA antibody (1:1000 dilution) (Roche Molecular Biochemicals, Mannheim, Germany). Immunoreactive proteins were detected using horseradishperoxidase-conjugated secondary antibody and visualized using the enhanced chemiluminescence detection system (Amersham Pharmacia Biotech).
In vitro translation
To examine whether sv proteins are translated in vitro, pc-wt, pc-sv1, pc-sv2, pc-sv3, and pc-sv4 were in vitro transcribed with T7 polymerase and translated using the rabbit reticulocyte lysate system according to the manufacturer's instruction (Promega Corp.). In vitro translated proteins were separated using 12% SDS-polyacrylamide gel and exposed to an x-ray film (Kodak). 
Ligand binding assay
Luciferase assay
HeLa cells were cultured in 24-well plates, and transfection was performed using the SuperFect transfection kit (QIAGEN). For each transfection, 50 ng of pc-wt, pc-sv1, pc-sv2, pc-sv3, or pc-sv4, 200 ng of pCREluc along with 200 ng of internal control plasmid pCMV␤Gal were used. The empty vector pcDNA3 was used to adjust the total amount of DNA transfected to 0.7 g. To demonstrate the dose-dependent effect of pc-sv's on pc-wt, 200 ng of pCREluc construct and 50 ng of pc-wt construct were cotransfected with various amounts of the pc-sv's (50 ng, 150 ng, and 250 ng, respectively). Forty-two hours post transfection, cells were treated with either mGnRH or cGnRH-II. Because we found, in a preliminary time-course experiment, that GnRHs exhibited highest activity in inducing luciferase reporter gene expression after 6 h treatment, we selected this period for GnRH treatment. After 6 h, cells were harvested and the luciferase activity in cell extracts was determined using a luciferase assay system according to standard methods in a Lumat LB9501 (EG & G, Berthold, Germany). The luciferase values were normalized by the ␤-galactosidase values used as an internal control for transfection efficiency. Transfection experiments were performed in triplicate and repeated at least three times.
Green fluorescent protein (GFP)-fusion constructs of bfGnRHR-3 cDNAs and confocal laser-scanning microscopy
The enhanced GFP (EGFP) coding region was fused in-frame to the C-terminal end of the bfGnRHR-3 wt and sv cDNAs by removing the stop codon using PCR. The following primers were used: GFP-start, 5Ј-CGCAAGCTTGCCACCATGAACGCTAGTGACCAACCTATGG-3Ј [containing an HindIII site (underlined), a Kozak translation initiation site (italics), and the N-terminal coding part of bfGnRHR-3 cDNA (bold)], and GFPwt-stop, 5Ј-CGCCTCACGGATCCCTCTCTACGATTTGACG-CTTACA-3Ј, or GFPsv1-stop, 5Ј-CGCCTCATGGATCCCCGCGGGAT-GTTGTTGTAGGAG-3Ј, or GFPsv2-4-stop, 5Ј-CGCCTCACGGATCC-AGATGCCGCTTCCCCTCACCTTCAG-3Ј, in which BamHI restriction sites (underlined) just in front of the stop codons (bold) were introduced. The PCR products were digested with HindIII and BamHI and ligated to HindIII and BamHI digested pEGFP-N1 plasmid, generating wtGFP and sv1-4GFP constructs. HeLa cells were transfected with pEGFP-N1 alone, or wtGFP, or the sv1-4GFP constructs. Cells were transferred onto sterile glass coverslips in 6-well plates 48 h after transfection. After growing for another 12 h, cells were washed with PBS and fixed in 4% paraformaldehyde at room temperature for 30 min. Fixed cells were washed with PBS and mounted on microscope slides with 50% (vol/vol) glycerol in PBS. Image analysis of GFP fluorescence in cells, transfected with pEGFP-N1 plasmid alone or with the various GFP-constructs, were performed under a Leica Corp. TCS-NT laser-scanning confocal microscope (Leica Corp., Heidelberg, Germany) equipped with an argon/ krypton laser using a 488 nm excitation filter and 515-540 nm band pass emission filters. The images of individual cells were manipulated on a Macintosh computer using the TCS-NT Image program (Leica Corp.).
RT-PCR analysis of bfGnRHR-3 sv mRNAs
Five micrograms of total RNA prepared from the pituitary and several brain tissues (olfactory lobe, telencephalon, hypothalamus, cerebellum, and spinal cord) of a pool of six frogs were reverse-transcribed and subjected to PCR. To examine the expression patterns of the bfGnRHR-3 sv mRNAs, PCR was performed using bf3-interF (5Ј-GC-GAAAAAGAAGAACAAGGCCATG-3Ј) and bf3-interR (5Ј-CTCATC-CGAGCCCGCGGGATG-3Ј) primers. PCR products were separated by agarose-gel electrophoresis, transferred to nylon membrane, and hybridized with radiolabeled bfGnRHR-3 cDNA. As an internal control, bullfrog GAPDH-specific primers, Rc-GAPDH-F (5Ј-CAATCCAAT-GGGGAGCTTCTG-3Ј) and Rc-GAPDH-R (5Ј-CAATCCAATGGG-GAGCTTCTG-3Ј) were used, generating a PCR product of 450 bp. The PCR cycling parameters were denaturation at 95 C for 30 sec, followed by 30 cycles at 94 C for 15 sec, at 50 C for 10 sec, and at 72 C for 30 sec. Although the results of these RT-PCR experiments can be considered only as qualitative, the intensity of each PCR-amplified band was analyzed to get an indication of quantitative differences in expression using image analysis software (TINA, Fuji Photo Film Co., Ltd.) after being photographed with a chemoluminescence camera. The data shown are band densities in arbitrary optical density units.
Data analysis
Binding assay and transfection experiments were performed in triplicate and repeated at least three times. Statistical analysis was performed by either one-or two-way ANOVA or t test. Statistical significance was set at P Ͻ 0.05.
FIG. 1. A, Presence of multiple gene transcripts of bfGnRHR-3. RT-
PCR was performed using cDNAs from different brain regions of the bullfrog. The sizes of the PCR products are indicated. The bfGnRHR-3 wt, sv2, sv3, and sv4 were isolated from 1.3 kb PCR products. Sv1 was isolated from 1.1-b PCR products. P, Pituitary; OL, olfactory lobe; T, telencephalon; H, hypothalamus; C, cerebellum; S, spinal cord. B, Schematic representation of the five bfGnRHR-3 mRNA isoforms (wt, sv1, sv2, sv3, and sv4) generated by alternative splicing such as exon skipping (sv1) and partial intron retention (sv2, sv3, and sv4). Sv1 is produced by deletion of exon 2 in the coding region, whereas sv2, sv3 and sv4 are produced by the partial insertion of 47, 94, and 100 nucleotides of intron B, respectively. Comparison of the sv4 cDNA and genomic bfGnRHR-3 DNA sequences indicates that the 6 additional nucleotides (represented by capital letters and underlined) in the sv4 cDNA are not present in the bfGnRHR-3 gene. Boxes represent the three exons, and solid lines indicate introns.
Results
Identification of five different, alternatively spliced bfGnRHR-3 transcripts
To determine whether bfGnRHR-3 sv's exist, RT-PCR analysis was performed using RNA samples obtained from different brain regions and pituitary of the bullfrog (sampled in January) with a set of specific primers flanking the entire bfGnRHR-3 coding region. Clear bands of approximately 1.3 kb and approximately 1.1 kb were observed after RT-PCR amplification using RNA from different brain regions, whereas weak bands were produced from the pituitary (Fig.  1A) . The 1.3-kb PCR product most likely corresponded to the previously identified bfGnRHR-3 cDNA (11), although the diffuse nature of the band suggested a mixture of multiple products with small differences in size, possibly derived from alternative splicing. The 1.1-kb product seemed to represent an unidentified sv form of bfGnRHR-3 mRNA. Sequence analysis revealed that the 1.1-kb product (designated sv1) lacked 204 bp between nucleotides 576 and 782 of the bfGnRHR-3 wt cDNA sequence. This truncation of the sv1 mRNA is most likely due to exon skipping during the premRNA splicing (Fig. 1B) . This exon skipping resulted in a frame shift and introduced a premature stop codon, generating a truncated protein of 211 amino acids. The 1.3-kb band contained at least four different cDNAs: bfGnRHR-3 (wt) and three additional bfGnRHR-3 cDNA sequences (designated sv2, sv3, and sv4) in which 47, 94, and 100 additional nucleotides were inserted between exons 2 and 3, respectively. Hence, these sv2, sv3, and sv4 cDNAs were produced by partial intron retention (Fig. 1B) . In addition, the sv4 cDNA contains an additional sequence (5Ј-AGCCAA-3Ј) that was not found in intron B of the bfGnRHR-3 gene. The retained intron sequence introduced two premature stop codons. Because the sv2, sv3, and sv4 share the same stop codon in retained intron B, the truncated bfGnRHR-3 proteins derived from sv 2-4 are identical in amino acid sequence.
Partial analysis of the bfGnRHR-3 gene
Comparison of PCR-amplified bfGnRHR-3 genomic sequences with the previously identified bfGnRHR-3 cDNA sequence revealed that the bfGnRHR-3 gene contains two introns at similar positions as found in mammalian GnRHR genes (19 -23) : intron A (ϳ0.6 kb), located in transmembrane domain (TM) IV, and intron B (ϳ2.4 kb), located in intracellular loop 3, respectively ( Fig. 2A) . However, we cannot exclude the possibility that additional introns are present in the 5Ј or 3Ј untranslated region of the bfGnRHR-3. The first intron (intron A) in the bfGnRHR-3 gene is much smaller than the intron found at the similar position in mammalian GnRHR genes (ϳ4-to 12-kb). The second intron is about 2.4 kb in size, which is very similar to the mammalian GnRH gene (ϳ3 kb). Exon-intron junction analyses indicated that the 5Ј splice site of intron B loosely conformed to the consensus sequence, and that two additional putative 5Ј splice sites are present within intron B. Comparison of the sv sequences with the partial bfGnRHR-3 gene sequences indicated that sv1 is generated by skipping of exon 2 (by using the normal 3Ј-splice site of intron A and the 3Ј-splice site of intron B), whereas sv2, sv3, and sv4 are generated by partial retention of intron B sequences during the splicing process (Fig. 2B) . Interestingly, alternative splicing of the GnRHR primary transcript, producing a mature mRNA with the complete deletion of exon 2, was also observed in mouse (19) and human (22) . This suggests that a common mechanism of alternative splicing is used in amphibians and mammals for their GnRHR genes. The alternative splicing events within intron B of the bfGnRHR-3 pre-mRNA further extend the observations found in mammalian GnRHR pre-mRNA splicing, and probably result from competition among three cryptic 5Ј splice sites present in this intron for the common 3Ј splice site of intron B (Fig. 2B) . These 5Ј splice sites loosely conformed to the metazoan consensus sequence, GTRAGT, in which the initial GT dinucleotide is almost invariant (Fig.  2B) (24, 25) . The 3Ј splice site of intron B is in accordance with the conserved consensus sequence Y n XCAG (25) . In addition, transcriptional slippage (26) appears to contribute to the generation of sv4, because 6 additional nucleotides found in this cDNA are absent in the genomic DNA (Fig. 2B) .
Expression of BfGnRHR-3 wt and sv1-4 proteins
To examine the protein expression of the wt and alternatively spliced bfGnRHR-3 transcripts, we transiently transfected constructs, harboring an amino-terminal HA tag inserted directly after the first methionine (i.e. the HA-wt, HA-sv1, HA-sv2, HA-sv3, and HA-sv4 cDNAs), into HeLa cells. Protein extracts were immunoprecipitated, electrophoresed on SDS-PAGE, and assayed after Western blotting with a monoclonal antibody directed against the HA epitope. This allowed the identification of immunoreactive bfGnRHR-3 proteins migrating at positions with molecular masses of 48 kDa in cells expressing the HA-wt protein (Fig. 3A, lane 1) , of 27 kDa in cells expressing the HA-sv1 protein (Fig. 3A, lane  2) , and of 34 kDa in cells expressing the HA-sv2, HA-sv3, and HA-sv4 proteins (Fig. 3A, lanes 3-5) . It is notable that there was no significant difference in expression levels among the wt and sv proteins. To examine the translation of sv's in vitro, the corresponding bfGnRHR-3 proteins were synthesized using an in vitro translation rabbit reticulocyte system. This result showed that bfGnRHR-3 proteins had similar molecular masses as found in transfected HeLa cells (Fig. 3B) The small difference in size between in vitro translated receptors and HeLa cell-expressed receptors is most likely due to use of different plasmids (HA-containing plasmids in HeLa cellexpressed receptor) or a posttranslational modification such as glycosylation in HeLa cells. The relative small protein size observed in sv proteins is due to early introduction of stop codon by frame shift (sv1) or intron B retention (sv2-4) (Fig. 3C ).
BfGnRHR-3 sv's have very low affinities to ligand
To examine the ligand-binding affinity of the sv's, membrane receptor binding assays were performed. The wt bfGnRHR-3 showed a high binding affinity, whereas each sv showed a very low binding affinity (Fig. 4A) 3 . A, Western blot analysis of the bfGnRHR-3 wt and sv proteins. Total protein extracted from HeLa cells expressing either HA-wt or HA-sv cDNA constructs were prepared as described in Materials and Methods. The protein extracts were immunoprecipitated and separated by SDS-PAGE and analyzed by immunoblot assay. B, In vitro translated pcbfGnRHR-3 proteins using the TNTcoupled reticulocyte lysate system according to the manufacturer's instruction. Note that the small differences in length found in panels A and B is likely generated by a posttranslational modification such as glycosylation. C, A simple diagram of wt and sv transcripts. Stop codons generated by frame shift (sv1) and intron B retention are indicated.
marginally bind to ligand, although they are expressed at the same level as the wt receptor as shown in Fig. 3A .
sv2, sv3, and sv4, but not sv1 inhibit wt bfGnRHR-3 receptor signaling
It has been shown that a sv of the human GnRHR inhibited the signal transduction activity of the wt receptor (27) . Given the predicted structure of the sv2-4 proteins, lacking the entire region from TM VI to the C-terminal tail, it is tempting to speculate that these isoforms may also interfere with the wt receptor function, as observed in the human GnRHR sv (27) . To examine this possibility, cotransfection experiments were performed. The pc-wt construct was cotransfected with each of the sv constructs, in combination with a luciferase reporter construct under the control of cAMP responsive element (CREluc), into HeLa cells. Although GnRHRs are generally considered to couple via Gq, substantial GnRHinduced cAMP production has been observed in cells transfected with GnRHR constructs (12, 28) , indicating that in addition to Gq, GnRHRs couple to Gs, then stimulating adenylate cyclase activity. Thus, cotransfection of GnRHR with CREluc construct could be useful tools for examining GnRHR-mediated signaling. Indeed, this tool has been confirmed to be useful for examining GnRHR sensitivity to a variety of ligands (29) . To allow an easy assessment of bfGnRHR-3 sv interference on wt receptor signaling, we assayed reporter activity 5 h after stimulation with GnRH. As shown in Fig. 5 , reporter gene expression was stimulated in a dose-dependent manner in response to mGnRH (Fig. 3A) or cGnRH-II (Fig. 5B ) in cells transfected with the pc-wt construct only. None of the four sv's alone was able to induce luciferase activity in response to mGnRH or cGnRH-II (Fig.  5, A and B) . The luciferase expression was increased 20-fold in the presence of 100 nm mGnRH (Fig. 5C ) or 1 nm of cGnRH-II (Fig. 5D ) in cells expressing the wt bfGnRHR-3 protein. Cotransfection with increasing amounts of pc-sv1 did not show any effect on the GnRH-induced luciferase gene expression in cells expressing pc-wt (Fig. 5, C and D) . However, cotransfection of increasing amounts of pc-sv2, pc-sv3, or pc-sv4 (from 50 -250 ng) constructs with constant amounts of the pc-wt (50 ng) construct, yielded a dose-dependent decrease of mGnRH-or cGnRH-II-induced signaling (Fig. 5,  C and D, respectively) . Although the inhibitory effect of pc-sv4 on pc-wt was relatively less than that of pc-sv2 and pc-sv3; statistically there was no significant difference in the repressive activity among these three isoforms. Similar results were obtained in HepG2 cells (data not shown).
bfGnRHR-3 sv's exhibit an impaired translocation to the cell membrane
Chimeric constructs, in which the GFP coding region was engineered in-frame to the C-terminal coding regions of the wt and sv1-4 receptors, were generated. Representative confocal microscope images of HeLa cells expressing the various GFP fusion proteins are shown in Fig. 6 . A highly localized, ring-like distribution of fluorescence was detected in cells expressing the wtGFP fusion protein (Fig. 6B) , indicating plasma membrane-associated localization of the wt receptor. The observed plasma membrane-associated fluorescence was generally even in terms of the intensity, although some cells showed a more punctuate fluorescence. In contrast, the distribution of the fluorescence in cells transfected with the GFP plasmid alone was diffuse, and present throughout the cytosol and nucleus (Fig. 6A) , consistent with GFP itself not being localized to any particular intracellular compartment, whereas no fluorescence was detected in untransfected cells (data not shown). The fluorescence corresponding to the sv1GFP was noticeably concentrated in the cytoplasmic compartment (Fig. 6C) . In cells, expressing the sv2-4GFP fusion proteins, a decreased membrane-associated fluorescence was visualized, accompanied by a larger amount of fluorescence in the endocytic vesicles (Fig. 6D) . It should be noted that because the sv2, 3, and 4 proteins are identical in amino acid sequence, the fusion of these sv2, 3, and 4 with GFP produces the identical protein.
Differential expression of the bfGnRHR-3 wt and sv RNA species in hibernation and the prebreeding season
To investigate whether alternative splicing of the bfGnRHR-3 pre-mRNA is differentially regulated under different physiological conditions, we used an RT-PCR based strategy to examine changes in wt and sv1-4 mRNAs from different bullfrog brain regions sampled in both hibernation (January) and prebreeding (May) season. The PCR was performed using a primer set designed to distinguish the variant RNA species. The sv1 (yielding a 140-bp PCR product) was constantly expressed throughout hibernation and the prebreeding season in the different brain regions (Fig. 7A) . The overall expression levels of wt (yielding a 345 bp PCR product) were significantly higher in the prebreeding season than in hibernation and appeared more abundant in midbrain and hindbrain regions. Because the differences in size of the sv2 (392 bp), sv3 (439 bp) and sv4 (445 bp) PCR products are too small to be clearly separated on agarose gel (Fig. 7) , we were unable to conclude whether there is a brain region-specific expression for each of these variant transcripts. In terms of overall expression level for these three transcripts (i.e. the upper band representing the mixture of sv2, sv3, and sv4 transcripts), it is apparent that the relative expression levels of sv2-4 were dramatically decreased from hibernation to the prebreeding season. We have compared the intensity of each EtBr-stained PCR band and calculated their absolute OD value (Fig. 7B) . In each brain region, the ratio of the band intensity of the wt to sv2-4 is 0.47 in pituitary (P), 0.95 in olfactory lobe (OL), 0.48 in telencephalon (T), 1.33 in hypothalamus (H), 0.76 in cerebellum (C), and 0.89 in spinal cord (S), respectively, in hibernation season, but increased to 3.76, 19.56, 4.0, 4.9, 3.2, and 5.1, respectively, in the same order in prebreeding season. Therefore, the total fold increase of the relative expression level of the wt to sv2-4 from hibernation to breeding season was 8, 20.6, 8.3, 3.7, 4.2, and 5.7, respectively. In addition, the primers specific for GAPDH mRNA (A and B) shows the GnRH-induced luciferase activity via the bfGnRHR-3 wt and sv proteins. HeLa cells were transfected with the bfGnRHR-3 wt or the sv cDNA constructs, respectively (50 ng/well in a 24-well plate), and dose-response curves to mGnRH or cGnRH-II were obtained. The lower panel (C and D) shows the results of cotransfection experiments. HeLa cells were transfected with constant amounts of bfGnRHR-3 wt cDNA construct (50 ng/well in a 24-well plate) in combination with increasing amounts of sv1, sv2, sv3, and sv4 cDNA constructs (for each: 50 ng, 150 ng, and 250 ng), respectively, supplemented with empty expression vector to keep the total amount of plasmid DNA constant. Luciferase activity in response to 100 nM of mGnRH (C) or 1 nM of cGnRH-II (D) was determined. Sv2, sv3, and sv4, but not sv1, exhibited a dose-response reduction in the GnRH-induced luciferase reporter gene activation via the wt receptor. One representative experiment of five is shown. Data are represented by means Ϯ SEM of triplication. *, P Ͻ 0.05 (vs. only wt transfection under stimulation of ligand).
amplified a PCR product of 450 bp with a similar intensity in all the tissues examined, verifying the quality and integrity of the cDNA samples (Fig. 7A) . Moreover, Southern blot analysis was performed, confirming the RT-PCR amplified products being bfGnRHR-3 specific (data not shown).
Discussion
In the present study, we have demonstrated that at least five different mRNA species are generated from a single bfGnRHR-3 primary transcript by alternative RNA splicing. Furthermore, we characterized the putative intracellular function and the subcellular localization of the proteins derived from each bfGnRHR-3 sv. Transfection studies revealed that none of four truncated proteins was able to increase GnRH-induced luciferase reporter gene expression. However, sv2, sv3, and sv4 could inhibit wt receptor signal transduction in a dose-dependent manner. Furthermore, the seasonal changes in ratio of the wt to sv's RNA levels indicate a potential role of sv's in the regulation of wt signaling under physiological conditions.
Alternative RNA splicing is a commonly used strategy for creating a functionally diverse pool of gene products derived from a single gene, which is recognized as an important mechanism for the regulation of the wt receptor function (30, 31). In mammalian species, a single GnRHR gene generates multiple transcripts by alternative splicing and/or different use of transcriptional initiation sites (19, 20, 22) . However, the functional relevance of these transcripts is poorly understood. The present study indicates that the bfGnRHR-3 gene produces at least five different RNA species by exon skipping and intron retention. Interestingly, exon 2 deletion was also found in the mammalian GnRHR gene (19, 22) , indicating that the splicing pattern of GnRHR transcripts may be evolutionary conserved. Exon 2 deletion and intron B retention introduced premature stop codons, producing truncated protein. Immunoblot analysis and in vitro translation assay revealed that these truncated proteins are expressed with no significant differences in expression levels compared with that of the wt protein. However, these sv proteins exhibited a very low binding affinity to GnRH and were not able to induce signal transduction. The failure to induce signal transduction is most likely due to either low ligand binding affinity or lack of a key motif in the receptor that is involved in signal transduction. The low binding affinity of sv proteins may result from the truncated nature even though they have putative ligand binding sites (Asp 98 , Asn 102 , and Lys 121 at the homologous position of human GnRHR) (11, 32, 33) . The early introduction of stop codon generated proteins that lack TM5/6/7 or TM6/7 in sv1 and sv2-4, respectively. TM7 is known as a crucial counter part of interaction with TM2, which can stabilize receptor structure and provide signaling ability (17, 34, 35) . Alternatively, a very low affinity of sv proteins to ligand may be due to an impaired translocation of sv proteins to cellular membrane. Confocal microscopy studies revealed that the wt receptor protein was membraneassociated, whereas sv's were located somewhat differently. The sv1 protein was present only in the cytosol, indicating that the deletion of exon 2 seriously impairs the proper translocation of the truncated sv1 receptor into the cell membrane. The other sv's (sv2-4) were expressed in both the cell membrane and cytosol. Therefore, it is assumed that such truncations affect the efficient translocation of these proteins to the cell membrane, which may provide little chances to bind with ligand. The other reason for the lack of signaling ability may be the absence of NPX 2-3 Y motif in TM7 that is involved in signal transduction in rhodopsin-like G protein-coupled receptors (GPCRs) (36). Because this motif is completely absent in these sv-derived proteins (for bfGnRHR-3: such as Ala 278 , Asp 338 and DPITY at the homologous position), it is evident that they would lose the ability to induce signal transduction.
Although these sv proteins showed very low binding affinities to ligand and absence of signaling ability via the cAMP signal transduction pathway in transfected cells, they were able to inhibit wt receptor signaling when cotransfected. Similar finding was observed in the human GnRHR system (27) . A sv of the human GnRHR exhibited a specific and dose-dependent inhibition of GnRH-induced wt receptor signal transduction (27) . It is also notable that the sv cDNAs of the bullfrog were more sensitive in inhibiting GnRH-induced wt receptor signaling than that of human GnRHR. In case of human GnRHR, an approximately 8-to 15-fold excess sv was required for inhibition of wt signaling (27) , whereas a 3-fold excess of bfGnRHR sv's was enough to inhibit wt signaling. Considering a high expression of sv's RNA transcripts in hibernation season, bfGnRHR sv proteins may regulate the wt receptor function in this season. However, it is not easy to explain how these sv proteins interfere with wt signaling. A competition between truncated receptor and the wt receptor for ligands may not be the case because the sv proteins have extremely low binding affinities. One possible explanation is that coexpression of sv's with the wt receptor may decrease membrane expression of the wt receptor as demonstrated by a recent study (27) . This interpretation is based on the possible defective intracellular transport due to the formation of misfolded complexes between wt receptor and truncated protein in the endoplasmic reticulum. This possibility is supported by two facts: the GnRHR appears to have two receptor folding units (TM1-5 and TM6 -7) (27) and individual ␣-helices are assumed to be inserted into membranes of the endoplasmic reticulum in proper orientation followed by tight packing that is mediated by specific interhelical interaction (37, 38). Thus, it is possible that TM1-5 of sv proteins may physically interact with TM6 -7 of the wt receptor, rustling in a reduced membrane expression. However, the failure of sv1 to inhibit wt receptor signaling could not be explained by the above interpretation. The alternative interpretation, therefore, is that sv proteins (sv2-4 but not sv1) expressed in the cell membrane could physically interact with the agonist-occupied wt receptor, subsequently resulting in a reduced signaling. Currently, there are increasing lines of evidence indicating that G protein-coupled receptors could function as dimers (homo-or hetero-or multimers) (39). A recent study using fluorescence resonance energy transfer analysis clearly demonstrated that the GnRHR can form dimers or multimers after agonist but not antagonist binding (40). Because the receptor microaggregation is an early event (Ͻ1 min) of agonist occupancy of the receptor, such a microaggregation appears a component of signal transduction, leading to the agonist activation of the receptor. Therefore, it is possible that an interaction of the agonist-occupied wt receptor with truncated receptor may interfere with wt receptor signaling. Considering the fact that sv2-4 (that could be expressed in the cell membrane) but not sv1 (expressed only in the cytoplasm) could inhibit the wt receptor signaling, the membrane expression of truncated protein appears a prerequisite for inhibition of wt signaling. However, elucidation of the detailed molecular mechanism under which sv inhibits wt receptor signaling will require further studies such as cellular distribution of wt bfGnRHR-3-GFP in the presence of sv proteins, coimmunoprecipitation of wt receptor and sv proteins, and fluorescence resonance energy transfer analysis(40) or bioluminescence resonance FIG. 7 . A, Analysis of brain-specific expression and seasonal variation of the bfGnRHR-3 wt and sv mRNAs using an RT-PCR. Copy DNA was prepared from 5 g of total RNA from six brain regions of hibernation (January) and prebreeding season (May). PCR was performed using gene specific primers designed to distinguish the variant RNA species. The positions of PCR products corresponding to the bfGnRHR-3 wt and sv transcripts are indicated on the right, and are also diagrammatically represented on the left. RT-PCR for bullfrog GAPDH was performed as internal control. For brain region abbreviations: see detail in Fig. 1A . B, Optical densities of the PCR bands are shown, allowing the comparison of the relative expression levels of the variant bfGnRHR-3 transcripts in different brain regions in both seasons.
energy transfer analysis (41) for examining direct physical interaction wt receptor and sv's.
A particularly interesting finding was the differential expression of the bfGnRHR-3 wt and sv mRNAs under different physiological conditions. The ratios of wt/sv mRNAs were much higher in the prebreeding season than those observed during hibernation (Fig. 7) . Thus, it appears that the inhibitory effect of sv's on wt functioning can vary in different seasons, such that it may be more effective in inhibition of wt receptor signaling in hibernation than in the prebreeding season. Recently, it has been reported that there is a variable expression of differently sized GnRHR transcripts in cyclic ewes (42), although the significance of this finding is yet unclear. Differential expression levels of sv's and wt indicate that the mechanism generating the sv's may play an important role in the regulation of the wt receptor signaling under different physiological conditions.
In addition, it should be also noted that the wt bfGnRHR-3 expression was markedly augmented in the pituitary gland in the prebreeding season. In our previous study (11) , we clearly demonstrated by Northern blot analysis the predominant expression of bfGnRHR-1 in the pituitary, whereas bfGnRHR-3 was localized in the brain regions. The expression of the wt bfGnRHR-3 receptor in the pituitary in prebreeding season, as revealed by the more sensitive RT-PCR approach in this study, raises the possibility that bfGnRHR-3 may also participate in the neuroendocrine function as does the bfGnRHR-1, allowing reproductive activity of the frog. However, regarding the much higher expression level of bfGnRHR-1 than bfGnRHR-3 in the pituitary, it is reasonable to assume that bfGnRHR-1 plays the major role in regulating reproductive function in the bullfrog.
In summary, we have identified five different transcripts of the bfGnRHR-3, generated by alternative splicing. The observations that the wt receptor signaling is inhibited by sv-derived proteins and that the seasonal changes in expression levels of the alternatively spliced transcripts occur, suggest that posttranscriptional regulation of the bfGnRHR-3 gene is an important mechanism in regulating the wt receptor function under different physiological conditions.
